Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

ABSTRACT:

SUBMITTER: Vinh DC 

PROVIDER: S-EPMC8186356 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature